This global patient registry is being conducted to characterize the natural history and real-world clinical management of patients with AHP, and to further characterize the real-world safety and effectiveness of givosiran and other approved AHP therapies.
Study Type
OBSERVATIONAL
Enrollment
150
Incidence of Selected Events of Interest in AHP Patients
Selected events of interest are defined as hepatic events (including hepatic neoplasia), renal events, thromboembolic events, and pancreatitis.
Time frame: Up to 6 years
Annualized Rate of Porphyria Attacks
Porphyria attacks are defined as meeting all of the following criteria: an acute episode of neurovisceral pain in the abdomen, back, chest, extremities and/or limbs, no other medically determined cause, and requires treatment with intravenous (IV) dextrose or hemin, carbohydrates, or analgesics, or other medications such as antiemetics at a dose or frequency beyond the participant's usual daily porphyria management.
Time frame: Up to 6 years
12-Item Short Form Health Survey Version 2 (SF-12 V2) (Standard Version)
S-12 V2 is a 12-question measure capturing global quality of life and overall health status and evaluates the following 8 domains: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional, and mental health.
Time frame: Up to 6 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Clinical Trial Site
Birmingham, Alabama, United States
RECRUITINGClinical Trial Site
Gilbert, Arizona, United States
RECRUITINGClinical Trial Site
San Francisco, California, United States
RECRUITINGClinical Trial Site
Baltimore, Maryland, United States
RECRUITINGClinical Trial Site
Boston, Massachusetts, United States
RECRUITINGClinical Trial Site
Minneapolis, Minnesota, United States
RECRUITINGClinical Trial Site
New York, New York, United States
RECRUITINGClinical Trial Site
Winston-Salem, North Carolina, United States
COMPLETEDClinical Trial Site
Oklahoma City, Oklahoma, United States
RECRUITINGClinical Trial Site
Philadelphia, Pennsylvania, United States
COMPLETED...and 20 more locations